Medical device manufacturer Medtronic has received a warning letter from the FDA after it failed to publish a post market report concerning its stent graft AneuRx. The device was approved in 1999 and is used to treat aneurysms. The reporting requirements are a safeguard for consumers so that the device is used properly and functioning safely.